Allen R Harkness

Title: The Innovations of Allen R Harkness

Introduction

Allen R Harkness is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as AMPA antagonists. With a total of 5 patents to his name, Harkness continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents is a physical form of dihydro-2,3-benzodiazepine derivative. This compound, specifically (R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine, exhibits an X-ray powder diffraction pattern with d spacings at 10.61, 8.83, 6.78, 5.83, 4.13, and 3.74 Å. This innovative compound is recognized for its utility as an AMPA antagonist. Additionally, he has developed an alternate crystal form of Tazofelone, further showcasing his inventive capabilities.

Career Highlights

Harkness is currently employed at Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to focus on groundbreaking research and development in the pharmaceutical industry. His contributions have not only advanced scientific knowledge but have also had practical applications in medicine.

Collaborations

Throughout his career, Harkness has collaborated with esteemed colleagues such as Marvin M Hansen and Michael J Martinelli. These collaborations have fostered an environment of innovation and have led to the successful development of various pharmaceutical compounds.

Conclusion

Allen R Harkness exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborative efforts continue to make a significant impact on medical science. His work is a testament to the importance of research and development in creating effective therapeutic solutions.